| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/25/1996 | US5530102 Methods and compositions for the direct concentrated delivery of passive immunity |
| 06/25/1996 | US5530017 Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids |
| 06/25/1996 | US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| 06/25/1996 | US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography |
| 06/23/1996 | CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
| 06/20/1996 | WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 06/20/1996 | WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 06/20/1996 | WO1996013286A3 Modulation of cell proliferation and wound healing |
| 06/19/1996 | EP0716648A1 New 9-chloro-prostaglandin derivatives |
| 06/19/1996 | EP0716600A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
| 06/18/1996 | US5527831 Administering an ophthalmic solution of polyhyroxyalcohol such as sorbitol, mannitol, inositol or xylitol along with carrier to lower pressure |
| 06/18/1996 | US5527827 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 06/18/1996 | US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
| 06/13/1996 | WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 06/13/1996 | CA2204994A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 06/12/1996 | EP0537318B1 New non-hygroscopic mono-ammonium salts |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/11/1996 | US5525629 Inhibition of cytokine production |
| 06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 06/06/1996 | WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p |
| 06/06/1996 | WO1996016931A1 Metalloproteinase inhibitors |
| 06/06/1996 | WO1996016647A2 Use of chloride channel blockers for reducing intraocular pressure |
| 06/06/1996 | WO1996016642A1 Matrix type patch preparation |
| 06/06/1996 | CA2206303A1 Matrix type patch formulation |
| 06/06/1996 | CA2206123A1 Use of chloride channel blockers for reducing intraocular pressure |
| 06/06/1996 | CA2205972A1 Metalloproteinase inhibitors |
| 06/05/1996 | EP0714303A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents |
| 06/04/1996 | US5523301 Topically applying adrenergic blocking agent to eye to maintain retinal nerve fiber layer thickness, increase axoplasmic flow and decrease optic disc cupping and pallor; prophylaxis |
| 06/04/1996 | US5523296 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 05/30/1996 | WO1996016065A1 Heterocyclic compounds and their preparation and use |
| 05/30/1996 | WO1996016049A1 OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS |
| 05/30/1996 | WO1996016027A1 Matrix metalloprotease inhibitors |
| 05/29/1996 | EP0527748B1 Use of prostaglandin F3alpha as an ocular hypotensive agent |
| 05/29/1996 | CN1123276A Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 05/29/1996 | CN1123151A Medicine for treating decline of vision function resulted from glaucoma |
| 05/28/1996 | US5521216 Treating complications of diabetes |
| 05/28/1996 | US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome |
| 05/28/1996 | US5520926 Wound dressings |
| 05/28/1996 | US5520920 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 05/23/1996 | WO1996015108A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists |
| 05/23/1996 | WO1996014845A1 Nk-1 receptor antagonists for the treatment of eye disorders |
| 05/23/1996 | CA2205016A1 Nk-1 receptor antagonists for the treatment of eye disorders |
| 05/23/1996 | CA2204767A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists |
| 05/22/1996 | EP0712626A2 Use of R,S-(+/-)-alpha-Lipoic acid, S-(-)-alpha-Lipoic acid in reduced or oxidized form or their metabolites as well as their salts, esters, amides for the manufacture of rheological agents |
| 05/22/1996 | CN1123005A Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 05/21/1996 | US5519138 Angiotensin antagonist |
| 05/21/1996 | US5519054 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract |
| 05/21/1996 | US5518999 Method for treating Kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 05/21/1996 | US5518731 Nonaqueous fluorinated drug delivery vehicle suspensions |
| 05/17/1996 | WO1996014411A1 Methods for the diagnosis of glaucoma |
| 05/15/1996 | EP0711755A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 05/15/1996 | EP0465565B1 Treatment of aids dementia, myelopathy and blindness |
| 05/15/1996 | CN1122338A Physical form of dihydro-2,3-benzodiazepine derivative |
| 05/15/1996 | CN1122248A Insulin analog formulations |
| 05/14/1996 | US5516791 7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof |
| 05/09/1996 | WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 05/09/1996 | WO1996013286A2 Modulation of cell proliferation and wound healing |
| 05/09/1996 | WO1996013276A1 Ocular gene therapy |
| 05/09/1996 | WO1996013262A1 Muscarine antagonists |
| 05/09/1996 | WO1996013257A1 Use of receptor potentiators |
| 05/09/1996 | DE4439477A1 Use of alpha-liponic acid, its isomers and derivs. |
| 05/09/1996 | CA2203374A1 Ocular gene therapy |
| 05/09/1996 | CA2200886A1 Use of ner receptors potentiators |
| 05/09/1996 | CA2200468A1 Muscarine antagonists |
| 05/08/1996 | CN1122104A Gaba-Ergic modulation of eye growth |
| 05/07/1996 | US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 05/07/1996 | US5514686 Use of macrolide compounds for eye diseases |
| 05/02/1996 | WO1996012797A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012491A1 Method of inhibiting conditions associated with bradykinin |
| 05/02/1996 | CA2203914A1 Method of inhibiting conditions associated with bradykinin |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
| 05/01/1996 | EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them |
| 05/01/1996 | EP0709381A1 Heterocyclic compounds and their preparation and use |
| 05/01/1996 | EP0708776A1 Antiallergic imidazoazepines |
| 05/01/1996 | EP0606386B1 Dermatological and/or cosmetological composition containing retinoids |
| 05/01/1996 | CN1121717A Heterocyclic compounds and their preparation and use |
| 04/30/1996 | US5512581 Antiinflammatory agent |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011685A2 Use of indole derivatives for the treatment of various diseases |
| 04/25/1996 | CA2161176A1 Heterocyclic compounds and their preparation and use |
| 04/24/1996 | EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 04/24/1996 | EP0707495A1 Compositions for treating hypoxia-associated ocular complications |
| 04/24/1996 | EP0707487A1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/24/1996 | CN1121349A Heterocyclic compounds and their preparation and use |
| 04/24/1996 | CN1120934A Agent for treatment of glaucoma and agent for reducing eye pressure |
| 04/23/1996 | US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
| 04/23/1996 | US5510339 Method for the treatment of bronchial asthma by administration of topical anesthetics |
| 04/23/1996 | US5510101 Useful in treatment of keratoconjunctivitis sicca |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/17/1996 | EP0706994A1 Melatonergic agents |